4//SEC Filing
ESSEX WOODLANDS HEALTH VENTURES FUND VI L P 4
Accession 0001181431-09-011842
CIK 0000920465other
Filed
Feb 25, 7:00 PM ET
Accepted
Feb 26, 6:10 PM ET
Size
8.9 KB
Accession
0001181431-09-011842
Insider Transaction Report
Form 4
Transactions
- Sale
Common Stock
2009-02-26$0.05/sh−4,236,586$218,608→ 1,161,812 total - Sale
Common Stock
2009-02-24$0.07/sh−2,164,033$159,922→ 7,584,610 total - Sale
Common Stock
2009-02-25$0.06/sh−2,186,211$138,824→ 5,398,399 total
Footnotes (3)
- [F1]Represents the weighted average sale price of shares purchased by the Reporting Person in the price range of $0.07 to $0.10. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
- [F2]Represents the weighted average sale price of shares purchased by the Reporting Person in the price range of $0.06 to $0.07. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
- [F3]Represents the weighted average sale price of shares purchased by the Reporting Person in the price range of $0.05 to $0.06. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
Documents
Issuer
LA JOLLA PHARMACEUTICAL CO
CIK 0000920465
Entity typeother
Related Parties
1- filerCIK 0001276801
Filing Metadata
- Form type
- 4
- Filed
- Feb 25, 7:00 PM ET
- Accepted
- Feb 26, 6:10 PM ET
- Size
- 8.9 KB